Literature DB >> 15130908

Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.

Anthony P Khalifah1, Ramsey R Hachem, Murali M Chakinala, Kenneth B Schechtman, G Alexander Patterson, Daniel P Schuster, Thalachallour Mohanakumar, Elbert P Trulock, Michael J Walter.   

Abstract

Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, in part because its pathogenesis is poorly understood and treatment options are limited. To identify unique risk factors for BOS and death, we performed a retrospective cohort study on 259 consecutive adult lung transplant recipients over a 5-year period. The demographic and clinical characteristics of this population were analyzed for an association between BOS or death and potential risk factors, including community-acquired respiratory viral (CARV) infections, acute rejection, and cytomegalovirus pneumonitis. Respiratory syncytial virus, parainfluenza, influenza, and adenovirus accounted for 21 CARV infections. Univariate and multivariate time-dependent Cox regression analyses demonstrated that this CARV group was more likely to develop BOS, death, and death from BOS. Furthermore, these trends were more pronounced in patients with evidence of lower respiratory tract-CARV (lower-CARV) infections. Notably, the CARV and lower-CARV infections were risk factors for BOS, death, and death from BOS distinct from the risk attributable to acute rejection. Identification of CARV and lower-CARV infections as BOS and mortality risk factors has important clinical implications and may provide insight into disease pathogenesis and accelerate the development of novel treatment strategies to modify post-CARV BOS.

Entities:  

Mesh:

Year:  2004        PMID: 15130908     DOI: 10.1164/rccm.200310-1359OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  112 in total

1.  The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.

Authors:  A DerHovanessian; S S Weigt; V Palchevskiy; M Y Shino; D M Sayah; A L Gregson; P W Noble; S M Palmer; M C Fishbein; B M Kubak; A Ardehali; D J Ross; R Saggar; J P Lynch; R M Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2015-10-13       Impact factor: 8.086

Review 2.  Pathogenesis of respiratory syncytial virus infection in the murine model.

Authors:  R Stokes Peebles; Barney S Graham
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

Review 4.  Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.

Authors:  Michael D Duncan; David S Wilkes
Journal:  Proc Am Thorac Soc       Date:  2005

5.  IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.

Authors:  Cassandra L Mikols; Le Yan; Jin Y Norris; Tonya D Russell; Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Roger D Yusen; Mario Castro; Elbert Kuo; G Alexander Patterson; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

6.  Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection.

Authors:  Ankit Bharat; Elbert Kuo; Deepti Saini; Nancy Steward; Ramsey Hachem; Elbert P Trulock; G Alexander Patterson; Bryan F Meyers; Thalachallour Mohanakumar
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

7.  Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants.

Authors:  Mikio Okazaki; Andrew E Gelman; Jeremy R Tietjens; Aida Ibricevic; Christopher G Kornfeld; Howard J Huang; Steven B Richardson; Jiaming Lai; Joel R Garbow; G Alexander Patterson; Alexander S Krupnick; Steven L Brody; Daniel Kreisel
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-23       Impact factor: 6.914

8.  Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season.

Authors:  Jill J Severson; Katelyn R Richards; John J M Moran; Mary S Hayney
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

9.  Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity.

Authors:  Stephen Chiu; Ramiro Fernandez; Vijay Subramanian; Haiying Sun; Malcolm M DeCamp; Daniel Kreisel; Harris Perlman; G R Scott Budinger; Thalachallour Mohanakumar; Ankit Bharat
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

Review 10.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.